Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-23T21:59:38.500Z Has data issue: false hasContentIssue false
  • English
  • Français

A METHOD FOR ASSESSING THE COST-EFFECTIVENESS AND THE BREAK-EVEN POINT OF CLINICAL PRACTICE GUIDELINES

Published online by Cambridge University Press:  20 May 2002

Afschin Gandjour  and
Karl Wilhelm Lauterbach
Afschin Gandjour
Affiliation:
University of Cologne
Karl Wilhelm Lauterbach
Affiliation:
University of Cologne
Get access Rights & Permissions [Opens in a new window]

Abstract

Assessing the costs and benefits of developing a clinical practice guideline is important because investments in guidelines compete with investments in other clinical programs. Despite the considerable number of guidelines in many industrialized countries, little is known about their costs and cost-effectiveness. The authors have developed specific measures to determine the cost-effectiveness of guidelines, using a German evidence-based guideline on obesity for the diagnosis and treatment of obese patients as a model. The measures are: the number of people needed to cure, the number of people needed to prevent from developing the disease in question, and the number of people to treat in order to break even.

Keywords

Practice guidelinesCostsCost-effectiveness
Type
Research Article
Information
International Journal of Technology Assessment in Health Care , Volume 17 , Issue 4 , October 2001 , pp. 503 - 516
Copyright
© 2001 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)